Regulatory T (T reg) cells are subsets of CD4 + T cells that play crucial roles in immunological tolerance, transplantation, and autoimmunity (1-3). Among diff erent types of T reg cells, naturally arising CD4 + CD25 + T reg cells are the best characterized and studied. These cells comprise ‫%01-5ف‬ of CD4 + T cells in peripheral lymphoid organs and represent a unique T cell lineage that undergoes thymic selection and migrates to the periphery (4-8). Natural T reg cells are characterized by cell surface expression of CD25 (the IL-2 receptor α-chain), CD62L (L-selectin), cytotoxic T lymphocyte antigen 4, and glucocorticoid-induced TNF receptor (GITR). The role of T reg cells in control of autoimmune diseases was clearly demonstrated in the experimental models in which elimination of CD25 + T cells results in acceleration of disease progression including infl ammatory bowel disease, experimental autoimmune encephalomyelitis, and autoimmune diabetes (9).
Regulatory T (T reg) cells are subsets of CD4 + T cells that play crucial roles in immunological tolerance, transplantation, and autoimmunity (1) (2) (3) . Among diff erent types of T reg cells, naturally arising CD4 + CD25 + T reg cells are the best characterized and studied. These cells comprise ‫%01-5ف‬ of CD4 + T cells in peripheral lymphoid organs and represent a unique T cell lineage that undergoes thymic selection and migrates to the periphery (4) (5) (6) (7) (8) . Natural T reg cells are characterized by cell surface expression of CD25 (the IL-2 receptor α-chain), CD62L (L-selectin), cytotoxic T lymphocyte antigen 4, and glucocorticoid-induced TNF receptor (GITR). The role of T reg cells in control of autoimmune diseases was clearly demonstrated in the experimental models in which elimination of CD25 + T cells results in acceleration of disease progression including infl ammatory bowel disease, experimental autoimmune encephalomyelitis, and autoimmune diabetes (9) .
Multiple signaling pathways govern the development, function, and homeostasis of natural T reg cells including the IL-2 (10-15) and CD28 signaling pathways (16) (17) (18) . In addition, the forkhead transcription factor, Foxp3, has recently been shown to be an essential regulator of CD4 + CD25 + T reg cell development (19) (20) (21) . Studies using Foxp3 knock-out mice (Foxp3 −/− ) have shown that ablation of Foxp3 expression results in mice lacking CD4 + CD25 + T reg cells and the development of the lethal lymphoproliferative autoimmune disease characterized by the uncontrolled proliferation of activated T cells. This disease can be prevented by transfer of CD4 + CD25 + T reg cells. Moreover, overexpression of Foxp3 in CD4 + CD25 − T cells converts these lymphocytes into CD4 + CD25 + T cells with suppressive biological function (21) . These fi ndings suggest an obligatory role of Foxp3 in the development of natural T reg cells.
Engagement via the TCR is required for CD4 + CD25 + T cell development (22) (23) (24) (25) (26) . TCR engagement activates tyrosine kinases that further phosphorylate many cellular proteins, leading to activation of signaling events such as Ras-MAPK activation and calcium fl ux. A key protein that couples the signaling events to TCR engagement is the linker for activation of T cells (LAT) (27) . LAT is a transmembrane adaptor protein that binds Grb2, Gads, and PLC-γ1. It is essential during T cell activation and thymocyte development (28) . In addition, LAT also plays an important role in immune homeostasis. Mice with a knock-in mutation of LAT at the PLC-γ1 binding site (Y136) show a severe autoimmune disease (29, 30) . Although TCR-mediated phosphorylation of LAT and PLC-γ1 and Ca2 + mobilization in LATY136F T cells are markedly reduced, T cells in these mice are hyperactivated and produce large amounts of Th2 cytokines, which promotes B cell maturation and isotype switching. Spleens of these mice are enlarged enormously and lymphocytes infi ltrate into diff erent organs. It is not clear what causes the severe autoimmune phenotype in these mice. Defects in TCR signaling in LATY136F T cells might aff ect negative selection as demonstrated recently (31) , leading to production of autoreactive T cells in these mice. In addition, the signaling defects might also aff ect development or survival of CD4 + CD25 + T reg cells that are capable of controlling the autoimmunity. In this study, we demonstrated that LATY136F mice lacked CD4 + CD25 + T cells expressing Foxp3 in peripheral lymphoid organs. Moreover, transfer of normal CD4 + CD25 + T reg cells in LATY136F mice prevented the lymphoproliferative syndrome. Ectopic expression of Foxp3 in LATY136F T cells conferred suppressive function to abrogate lymphoproliferative disease when transferred into LATY136F mice. Our fi ndings provide the evidence that the proximal signaling pathways downstream of the TCR, specifi cally the LAT-PLC-γ1 interaction, control T cell homeostasis by regulating Foxp3 expression and development of T reg cells.
RESULTS

The absence of CD4 + CD25 + T cells in LAT Y136F mice
The interaction of the TCR and self-peptides presented by MHC class II plays a critical role in development of CD4 + CD25 + T reg cells in the thymus and function in the periphery (6, 32) , suggesting that TCR-mediated signaling might also be important in the development of T reg cells. We asked whether the severe autoimmune phenotype of the LAT Y136F mice might be caused by a defect in development or function of T reg cells. We fi rst examined whether CD4 + CD25 + T reg cells were present in LAT Y136F mice. Cells from thymuses and spleens of LAT Y136F and WT mice were analyzed for expression of CD4, CD8, and CD25 by FACS. As previously reported (29, 30) , LAT Y136F mice had a partial block in thymocyte development with accumulation of CD4 − CD8 − cells (Fig. 1 A) . Splenomegaly and enlarged lymph nodes became obvious when they were 4-6 wk old. In the periphery, the CD4 + to CD8 + ratio was skewed toward CD4 + cells. Although discreet populations of CD4 + CD25 + and CD4 + CD25 − SP thymocytes could be observed in WT mice, most of CD4 + SP thymocytes in LAT Y136F mice expressed low levels of CD25 (Fig. 1 A) . The 
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aberrant expression of CD25 in LAT Y136F thymocytes is likely caused by the partial block of thymocyte development in the DN3 (double negative) stage (29, 30) , in which thymocytes are CD25 + CD44 − . Interestingly, double positive thymocytes in LAT Y136F mice also expressed CD25 (not depicted). Thymocyte development in LAT Y136F mice might proceed without down-regulation of CD25 expression.
Because thymocytes from LAT Y136F mice expressed CD25, we next examined whether CD4 + CD25 + T cells are present in the periphery. CD4 + CD25 + T cells were clearly missing in the periphery of these mice (Fig. 1 A) (Fig. 1 B) . To exclude the possibility that decreased Foxp3 expression in CD4 + T cells from the mutant mice refl ected dilution of Foxp3 + cells because of the expansion of CD4 + T cells, Foxp3 expression in thymocytes and splenocytes from WT and LAT Y136F mice was examined by intracellular staining with an anti-Foxp3 antibody followed by fl ow cytometry. As shown in Fig. 1 C, only CD4 + SP thymocytes and CD4 + splenocytes derived from WT, not those from LAT Y136F mice, expressed Foxp3. Thus, LAT Y136F mice lack CD4 + CD25 + T reg cells.
To exclude the possibility that the severe autoimmune conditions cause disappearance of T reg cells, we also examined development of T reg cells in younger mutant mice in which the autoimmune disease was not severe. As a result of a partial block in thymocyte development, very few CD4 + or CD8 + T cells were found in the peripheral lymphoid organs of 17-d-old mice (not depicted); however, they appeared in the spleens from 24-d-old mice (Fig. 2 A) . Interestingly, a high percentage of CD4 + SP thymocytes expressed CD25 (23.6%). There was also a higher percentage (1.23%; Fig.  2 A) of CD4 + CD25 + splenocytes compared with 6-wk-old mice (0.1%; Fig. 1 A) . However, these CD4 + cells from the mutant mice did not express Foxp3 as indicated by intracellular staining ( Fig. 2A) . We also performed a mixed bone marrow chimeras experiment. Lethally irradiated LAT −/− mice were transferred with mixed bone marrow cells from WT Thy1.1 + and LAT Y136F Thy1.2 + mice. 6 wk after transfer, these mice showed no apparent signs of lymphoproliferative disease, whereas LAT −/− mice received bone marrow cells from LAT Y136F mice developed the autoimmune disease like LAT Y136F mice (not depicted). Because of the partial block in thymocyte development in LAT Y136F mice, fewer Thy1.2 + T cells than Thy1.1 + T cells were detected even though more bone marrow cells from LAT Y136F Thy1.2 + mice were transferred. As expected, WT Thy1.1 + bone marrow cells gave normal population of CD4 + CD25 + T cells. A small population of Thy1.1 + T cells expressed Foxp3, and these Foxp3 + cells also expressed CD25 (Fig. 2 B) . In contrast, very few Thy1.2 + cells in thymuses and spleens, if any, expressed Foxp3. Interestingly, diff erent from the 6-wk-old LAT Y136F mice with the autoimmune disease, a large percentage of Thy1.2 + CD4 + splenocytes expressed CD25. It is possible that CD25 expression is down-regulated with progression of the disease. Because these Thy1.2 + LAT Y136F T cells did not express Foxp3, they likely represented activated T cells. Collectively, these results indicate that LAT Y136F mice, which express a LAT mutant that does not bind PLC-γ1, have a defect in Foxp3 expression and development of CD4 + CD25 + T reg cells.
Adoptive transfer of CD4 + CD25 + T reg cells
To investigate whether the absence of CD4 + CD25 + T reg cells is indeed one of the underlying mechanisms responsible for the lymphoproliferative syndrome in LAT Y136F mice, we purifi ed CD4 + CD25 + or CD4 + CD25 − T cells from congenic Thy1.1 + mice by FACS sorting. 2-3 × 10 5 CD4 + CD25 + or CD4 + CD25 − Thy1.1 + T cells were transferred into 3-d-old Thy1.2 + LAT Y136F neonatal mice by i.p. injection. These mice were analyzed at 7 wk after injection. Untreated LAT Y136F mice clearly developed a pathological lymphoproliferative syndrome at 7 wk of age as shown before (29, 30) (Fig. 3 A) . Compared with untreated LAT Y136F mice, LAT Y136F mice that received Thy1.1 + CD4 + CD25 + T cells had a normal size spleen and lymph nodes. In contrast, LAT Y136F mice injected with CD4 + CD25 − T cells developed a lymphoproliferative syndrome similar to untreated LAT Y136F mice (Fig. 3 A) .
We further examined donor cell engraftment and expansion of adoptively transferred cells in LAT Y136F recipient mice. In normal mice, CD4 + CD25 + T cells comprise ‫%01-5ف‬ of the peripheral CD4 + T cells or ‫%2-1ف‬ of total cells in lymph node and spleen. FACS analysis 7-9 wk after adoptive transfer revealed that 1-2% of the total cells in the lymph node and spleen of LAT Y136F mice adoptively transferred with CD4 + CD25 + T cells were of donor origin, whereas very few donor cells were detected in the thymus (not depicted). This level of engraftment corresponded to ‫-9-4ف‬fold expansion of the initial donor cell inoculum of 2 × 10 5 cells. A similar degree of donor CD4 + CD25 + T cell expansion was observed after injection of CD4 + CD25 + T cells into Foxp3 sf neonates (21) . Likewise, CD4 + CD25 − injected into LAT Y136F neonates also underwent a considerable degree of expansion as the number of Thy1.1 + CD4 + CD25 − T cells increased 
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at least 20-fold (not depicted). In contrast, only very few donor-derived CD4 + CD25 + and CD4 + CD25 − cells were detectable when they were transferred into age-matched WT recipients, which had normal T cell compartment. This observation reconciles with the possibility proposed by Fontenot et al. that donor CD4 + CD25 + T cells can expand to fi ll the available homeostatic niche despite a skewed T cell compartment in these mice (21) . In addition, adoptive transfer of WT CD4 + CD25 + and CD4 + CD25 − T cells into 3-wkold LAT Y136F mice that have not fully developed lymphoproliferative disease also resulted in expansion of both populations of donor-derived T cells (not depicted). However, only the transfer of CD4 + CD25 + T cells was able to partially suppress lymphoproliferative disorder in 3-wk-old LAT Y136F recipients (not depicted). Neonatal adoptive transfer might provide donor-derived CD4 + CD25 + T cell population with sufficient time to proliferate and suppress LAT Y136F T cells to fully suppress lymphoproliferative disorder. FACS analysis showed that in both groups of treated LAT Y136F mice >99% of the engrafted donor cells were still CD4 + T lymphocytes as expected. At least 75% of the donor CD4 + T cells expressed high levels of CD25 in the LAT Y136F mice transferred with CD4 + CD25 + T cells, whereas the absolute majority of the donor CD4 + T cells were still CD25 − in mice that received CD4 + CD25 − T cells. Adoptive transfer of either population of donor T cells had no eff ect on expression of CD25 on the host T cells (Fig. 3 B) .
No effect of donor T cells on the phenotypes of recipient T cells
To evaluate whether adoptive transfer of normal CD4 + CD25 + T cells could change activated phenotypes or other intrinsic properties in the recipient T cells leading to suppression of the lymphoproliferative disorder, thymocytes and splenocytes from LAT Y136F mice that received the adoptive transfer were analyzed and compared with those of untreated WT and LAT Y136F mice. Thymocyte development in LAT Y136F mice that received CD4 + CD25 + T cells was similar to that in untreated LAT Y136F mice (Fig. 4 A) . In fact, no substantial number of donor T cells was detected in the thymus of these mice (not depicted). However, the LAT Y136F mice transferred with CD4 + CD25 + T cells had a signifi cantly lower percentage of CD4 + T cells in the spleen ‫)%3ف(‬ compared with untreated WT (27%) and LAT Y136F (56%) mice. Despite a substantial reduction in the number of CD4 + T cells in LAT Y136F mice, donor CD4 + CD25 + T cells did not alter the activated phenotypes of LAT Y136F T cells as T cells from both treated and untreated LAT Y136F mice were identical (CD25 − TCRβ low CD62L low CD44 high ; Fig. 4 B) . In addition, T cells from treated LAT Y136F mice failed to mobilize Ca 2+ -like T cells from untreated LAT Y136F mice (not depicted). These results indicate that donor CD4 + CD25 + T cells did not change the activated phenotypes of LAT Y136F T cells based on these parameters we tested. Instead, CD4 + CD25 + T reg cells transferred into LAT Y136F mice likely suppress expansion of CD4 + LAT Y136F T cells.
Rescue of the autoimmune phenotype in LAT Y136F mice
To determine if transfer of CD4 + CD25 + T cells into LAT Y136F mice could correct the autoimmune disease, we performed a histological analysis of spleen, liver, and kidney from those mice. Histological sections from untreated LAT Y136F mice showed disorganized B and T cell zones in the spleen, lymphocyte infi ltration in the majority of portal veins and liver sinusoids, and immune complex deposition in the glomeruli of the kidneys (Fig. 5 A) . In contrast, tissue sections from LAT Y136F mice treated with CD4 + CD25 + T cells appeared relatively normal, although many Thy1.2 + T cells did appear in the B cell zone of the spleen (Fig. 5 A) . Histological analysis of the spleen, liver, and kidney of LAT Y136F mice that received CD4 + CD25 − T cells exhibited lymphoproliferative diseases similar to untreated LAT Y136F mice (not depicted).
Examination of serum antinuclear (not depicted) and anti-double stranded DNA antibodies revealed that LAT Y136F mice treated with CD4 + CD25 + T reg cells had comparable levels to WT controls (Fig. 5 B) . These data were in agreement with a reduction in the number of hyperactivated B cells (MHC class II hi or IgM − B220 + ) in LAT Y136F mice treated with CD4 + CD25 + T cells (Fig. 5 C) . In addition, the concentration of IgG1 (Fig. 5 D) or IgE (not depicted), two antibody isotypes dramatically elevated in LAT Y136F mice as a result of increased B cell maturation (29) , was signifi cantly reduced in mice treated with CD4 + CD25 + T cells. Collectively, our data indicate that adoptive transfer of CD4 + CD25 + T cells into LAT Y136F neonates can protect LAT Y136F mice from further developing lymphoproliferative syndrome.
Up-regulation of granzymes in transferred CD4 + CD25 + T cells CD4 + CD25 + T reg cells are capable of suppressing autoimmune disease; however, how these cells exert their sup pressive function is still not clear. Inhibitory cytokines such as IL-10 and TGF-β are considered to be the key molecules involved in T reg cell-mediated immunosuppression (33) . Recently, it was reported that CD4 + CD25 + T cells up-regulate granzyme B in vitro upon stimulation with anti-CD3 and IL-2 (34) . Whether this happens in vivo has not been demonstrated. We asked whether CD4 + CD25 + T reg cells upregulate granzymes (A and B) or inhibitory cytokines when they are transferred into LAT Y136F mice. At 7 wk after adoptive transfer of CD4 + CD25 + or CD4 + CD25 − Thy1.1 + T cells into LAT Y136F mice, donor cells were reisolated from these mice by FACS sorting. Because these Thy1.1 + CD4 + CD25 + T cells were placed in the autoimmune environment and capable of correcting the disease, they must be activated to exert their suppressive function. They were labeled as "activated" in Fig. 5 E. We also isolated Thy1.2 + CD4 + CD25 + and CD4 + CD25 − T cells from WT mice as "resting" T reg . Frozen sections were prepared from the spleens, livers, and kidneys of 7-to 9-wk-old untreated controls and treated LAT Y136F mice. Spleen and liver sections were stained with anti-B220 (blue) and anti-TCR-β (red). Kidney sections were stained with anti-mouse IgG-FITC (green) for glomeruli. Spleen and kidney photographs were taken at ×10 magnifi cation. Liver photographs were taken at ×100 magnifi cation. (Fig. 5 E) . Interestingly, Thy1.1 + CD4 + CD25 + T cells from neonatally injected LAT Y136F mice expressed high levels of granzyme A, granzyme B, and TGF-β RNAs compared with Thy1.2 + CD4 + CD25 + T cells (Fig. 5 E) , whereas their IL-10 expression was comparable to that of resting T reg cells (not depicted). This result is consistent with recent fi ndings in which a granzyme B-dependent mechanism was identifi ed as contact-mediated suppression by CD4 + CD25 + T cells in vitro (34) . Increased TGF-β expression could also function to suppress the expansion of CD4 + T cells from LAT Y136F mice. It is possible that transferred Thy1.1 + CD4 + CD25 + T cells use both cytokine-mediated and contact-mediated mechanisms to suppress hyperproliferative host CD4 + T cells in vivo. Although we have not demonstrated that increased granzymes or TGF-β indeed mediates suppression in LAT Y136F mice, our results show that T reg cells indeed up-regulate these proteins in the autoimmune environment.
Ectopic expression of Foxp3 in LAT Y136F T cells
Ectopic expression of Foxp3 was previously shown to be suffi cient to activate a program of immunosuppression in CD4 + CD25 − T cells (21) . Because Foxp3 expression was signifi cantly decreased in LAT Y136F T cells (Fig. 1, B and C) , we asked whether reexpression of Foxp3 in LAT Y136F T cells could confer the regulatory function that normal CD4 + CD25 + T cells have. Because LAT Y136F T cells express low levels of TCRs on their surface, they were diffi cult to be activated via the TCR. Instead, LAT Y136F T cells were stimulated with PMA and ionomycin and cultured in the presence of IL-2 for 48 h before transduction with retroviruses expressing Foxp3 and green fl uorescence protein (GFP) (pHSpG-Foxp3) or GFP alone (pHSpG-Empty) (Fig. 6 A) . After culture for an additional 48 h postretroviral transduction, GFP + CD4 + T cells were FACS sorted, and 2−3 × 10 5 purifi ed GFP + CD4 + LAT Y136F T cells were i.p. injected into 3-d-old LAT Y136F neonates. Expression levels of TCR-β and the GITR on transduced LAT Y136F CD4 + T cells with or without Foxp3 were similar, whereas those of CD25 were slightly higher on pHSpG-Foxp3-transduced cells (Fig. 6 A) . Expression of high levels of CD25 in these cells is likely a consequence of stimulation by PMA and ionomycin. 6 wk posttransfer, spleens and lymph nodes were harvested and examined. Mice receiving purifi ed LAT Y136F T cells expressing only GFP developed a severe lymphoproliferative syndrome like untreated LAT Y136F mice (Fig. 6 B) . In contrast, mice that received LAT Y136F T cells expressing Foxp3 and GFP exhibited no sign of lymphoproliferative disease as judged by the gross appearance of secondary lymphoid organs (Fig. 6 B) . Analysis of GFP − T cells from mice received CD4 + LAT Y136F T cells expressing Foxp3 and GFP revealed a dramatic decrease in CD4 + T cells similar to that observed in LAT Y136F mice that received normal CD4 + CD25 + T cells. On the other hand, GFP − host T cells from LAT Y136F mice treated with CD4 + LAT Y136F T cells expressing GFP alone were predominantly CD4 + similar to those in LAT Y136F mice (Fig. 6 C) . These data indicate that reconstitution of Foxp3 expression in LAT Y136F T cells is suffi cient to induce suppressive function and protect LAT Y136F mice from lymphoproliferative disease.
DISCUSSION
In this study, we demonstrated an essential role of the adaptor protein LAT in Foxp3 expression and CD4 + CD25 + T reg cell development. In LAT Y136F mice with a severe lymphoproliferative disease, CD4 + CD25 + cells were nearly absent in peripheral lymphoid organs. Foxp3 expression was also dramatically decreased in the LAT Y136F T cells. Interestingly, in young LAT Y136F mice CD4 + CD25 + cells could be found; however, they did not express Foxp3. Similar results were also seen in LAT −/− mice that received mixed WT and LAT Y136F bone marrow chimeras. These data indicate that the LAT-PLC-γ1 interaction is required for Foxp3 expression and T reg cell development. Severe lymphoproliferative disease in LAT Y136F knock-in mice could be prevented by transfer of normal CD4 + CD25 + T reg cells but not CD4 + CD25 − T cells. Our results indicate that the lymphoproliferative disease associated with the LAT Y136F mutation is not only caused by abrogation of central tolerance (31) , but also by a breakdown in peripheral tolerance caused by a severe block of CD4 + CD25 + T reg cell development.
Analysis of donor cell engraftment indicates that CD4 + CD25 + and CD4 + CD25 − T cells are able to proliferate and expand in LAT Y136F mice. Two studies using IL-2Rβ-and Foxp3-defi cient mice have previously demonstrated a similar expansion after the transfer of CD4 + CD25 + T reg cells (12, 21) . A rich Th2 cytokine environment, a consequence of hyperactivated LAT Y136F CD4 + T cells, may provide an ideal environment to support the expansion of transferred CD4 + CD25 + and CD4 + CD25 − T cells. In LAT Y136F mice, at 2-3 wk after birth both CD4 + and CD8 + T cells begin to fi ll in peripheral lymphoid organs as a result of a partial block in thymocyte development. Nonselective expansion of transferred T cells might be caused by the lymphopenic environment in neonatal LAT Y136F mice. Adoptive transfer of CD4 + CD25 + and CD4 + CD25 − T cells into 3-wk-old LAT Y136F recipient mice also allowed engraftment and expansion of both T cell populations. Thus, it is also possible that this expansion of transferred T reg cells may result from a proliferative response to fi ll a homeostatic niche for CD4 + CD25 + T cells (10, 35) . Although donor-derived CD4 + CD25 − T cells expanded upon transfer into LAT Y136F neonates, only transfer of CD4 + CD25 + T cells into LAT Y136F mice rescued the lymphoproliferative disease. Even though CD4 + CD25 − T cells could convert into CD4 + CD25 + T cells upon homeostatic proliferation (36), CD4 + CD25 − T cells injected into neonatal or 3-wk-old LAT Y136F mice neither converted into a considerable number of CD4 + CD25 + T cells nor rescued the lymphoproliferative disease.
The appearance of CD4 + CD25 + LAT Y136F T cells in peripheral lymphoid organs of mixed bone marrow chimeras or young mutant mice was unexpected because CD25 expression was almost absent on CD4 + T cells from LAT Y136F mice older than 6 wk. However, in mice that received treatment of CD4 + CD25 + at the neonatal stage CD25 expression on LAT Y136F CD4 + T cells was still missing. Regardless of CD25 expression in LAT Y136F T cells from diff erent mice, Foxp3 expression was not detected in these cells, suggesting that these cells are likely activated T cells, not real T reg cells. It is possible that IL-2 produced by WT T cells might induce or maintain a high expression level of CD25 on LAT Y136F T cells or the autoimmune environment in LAT Y136F mice may cause T cells to gradually lose CD25 expression. Neonatally injected T reg cells, which do not secret IL-2 (4, 22, 37), failed to restore CD25 expression on LAT Y136F T cells in these mice and provided only protective function against lymphoproliferative disease. Previous studies show that Foxp3 is up-regulated upon activation of CD4 + CD25 + T reg cells, and that ectopic Foxp3 expression confers suppressor function upon peripheral CD4 + CD25 − T cells (21) . Likewise, ectopic expression of Foxp3 conferred LAT Y136F CD4 + T cells a regulatory function that prevents autoimmunity in these knock-in mice. Although ectopic expression of Foxp3 had no eff ect on the levels of both TCR-β and GITR, CD25 was slightly up-regulated on transduced CD4 + T cells of LAT Y136F mice. It is diffi cult to conclude the eff ect of Foxp3 on CD25 in our experiments because we had to activate LAT Y136F T cells with PMA and ionomycin, which upregulate CD25 in vitro, before transducing these cells with retroviruses. Nevertheless, our results suggest that Foxp3-mediated suppression does not require normal function of LAT, perhaps independent of the TCR. Our data strongly support the notion that Foxp3 is a master regulator gene that controls suppressor function in CD4 + CD25 + T cells. 
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The LAT-PLC-γ1 interaction is important in TCRmediated Ca 2+ fl ux and MAPK activation (38, 39) . LAT Y136F T cells have abrogated Ca 2+ fl ux although TCR-mediated MAPK activation is normal (30) . As the infl ux of extracellular Ca 2+ after TCR engagement has been implicated in infl uencing the outcome of both positive and negative selection (40) (41) (42) , it is also possible that TCR-mediated Ca 2+ mobilization and further NFAT activation might be required for induction of Foxp3 expression. Interestingly, the phenotype of LAT Y136F mice resembles that of mice lacking NFATc2 and NFATc3 (43) , which suggests that the autoimmune disease in these mice may be attributed, at least in part, to a decrease in NFAT activation. However, it has been demonstrated that combined NFATc2/c3 defi ciency has no eff ect on development and function of CD4 + CD25 + T cells but renders CD4 + CD25 − T cells unresponsive to suppression (44) . Based on these fi ndings, we speculate that the LAT-PLC-γ1 interaction provides signals other than NFAT activation to induce Foxp3 expression. Because LAT Y136F CD4 + T cells can be suppressed in vivo, NFATc2/c3, which are required for CD4 + CD25 − T cells to be suppressed, might be activated independent of the TCR. Although our results indicated that the LATY136F mutation aff ected Foxp3 expression and T reg cell development, we cannot rule out the possibility that the LAT Y136F T reg cells can develop, but they might not be able to survive in these mice. In addition, because T cell development is partially blocked in the LAT Y136F mice, it is possible that the defect in Foxp3 expression and T reg cell development might be indirect consequences of the block in thymocyte development. The signaling pathways that link the LAT-PLC-γ1 association and Foxp3 expression or T reg cell development remain to be explored in the future.
A dramatic decrease in peripheral CD4 + T cells in treated LAT Y136F mice strongly indicates that these autoreactive CD4 + T cells are the targets of CD4 + CD25 + T cell-mediated suppression. Our data show that donor-derived CD4 + CD25 + T cells from treated LAT Y136F mice expressed high levels of granzyme A, granzyme B, and TGF-β compared with CD4 + CD25 + T cells isolated directly from WT mice (Fig.  5 E) . In normal mice, maintenance of central tolerance mechanisms by negative selection leaves only a scanty number of these potentially harmful T cells in the periphery. The majority of T reg cells may never encounter these self-reactive T cells and thus remain at the resting status. Once placed or exposed to the autoimmune conditions, CD4 + CD25 + T reg cells may trigger both contact-dependent and cytokinemediated mechanisms by secretion of granzymes and TGF-β. Whether these proteins indeed function to kill or suppress CD4 + LAT Y136F T cells in vivo remains to be determined in the future. In conclusion, our study indicates that the proximal signaling pathways downstream of the TCR mediated by the LAT-PLC-γ1 interaction play an important role in CD4 + CD25 + T cell development and opens up the question of what might be the missing link between TCR and Foxp3 induction.
MATERIALS AND METHODS
Mice. All mice were used in accordance with the National Institutes of Health guidelines. The experiments described in this study were reviewed and approved by the Duke University Institutional Animal Care and Use Committee. Mice were housed in specifi c pathogen-free conditions at the Duke University Animal Care facility.
Antibodies. Streptavidin-conjugated Texas red and PE-Cy7 and biotinylated FITC, PE, and PE-Cy5, APC-conjugated antibodies to TCR-β, CD4, CD8α, CD25, B220, CD62L, CD44, GITR, Thy1.1, Thy1.2, IgM, IA b , and mouse Ig were purchased from BD Biosciences. The anti-Foxp3 antibody was from eBioscience.
Cell purifi cation. Cells were maintained in complete RPMI 1640 medium with 10% FCS. To isolate CD4 + CD25 + and CD4 + CD25 − T cells, splenocytes and lymph node cells were isolated. CD8 + T and B cells were depleted by magnetic beads using biotin-conjugated anti-CD8 and anti-B220. The enriched CD4 + lymphocytes were stained with FITC-anti-CD4, PE-anti-CD25, and 7AAD. CD4 + CD25 + and CD4 + CD25 − T cells were purifi ed by cell sorting using a FACSVantage SE fl ow cytometer (BD Biosciences).
Neonatal transfer of CD4 + T cells. 2-3 × 10 5 WT Thy1.1 + -marked CD4 + CD25 + or CD4 + CD25 − T cells were injected i.p. into 3-d-old (Thy1.2 + ) LAT Y136F pups or 3-wk-old LAT Y136F mice. These LAT Y136F pups were derived from breeding LAT +/Y136F females with LAT −/− males. Injected pups were analyzed at 7−9 wk after the adoptive transfer. Donor cell recovery was calculated based on the total number of lymphocytes multiplied by the percentage of Thy1.1 + cells as determined by FACS analysis.
Mixed bone marrow transfer. T cell-depleted bone marrow cells from Thy1.2 + LAT Y136F mice (3.0 × 10 6 cells) were mixed with Thy1.1 + congenic mice (1.5 × 10 6 cells) and were then injected i.v. into irradiated LAT −/− mice (900 rads). 6 wk after bone marrow reconstitution, thymuses and spleens were harvested and analyzed by FACS.
Retroviral transduction of LAT Y136F CD4 + CD25 − T cells. pHSpG and pHSpG/Foxp3 retroviral vectors were used to transfect the Phoenixecotropic virus packaging cell line using the calcium phosphate method to produce recombinant retroviruses. To transduce T cells from LAT Y136F mice, splenocytes from LAT Y136F mice were fi rst activated using 40 ng ml −1 PMA and 0.5 μg ml −1 ionomycin and recombinant mouse IL-2 (100 ng ml −1 ) for 36 h. Activated lymphocytes were then transduced by mixing with the retroviral supernatant in the presence of 8 μg ml −1 polybrene and recombinant mouse IL-2 (100 ng ml −1 ). Cells were then centrifuged at 1,300 g for 2 h at 22°C. After culturing those cells at 37°C for 24 h, the transduction procedure was repeated. At 48 h after viral transduction, GFP + CD4 + T cells were sorted by FACS and 2−3 × 10 5 GFP + CD4 + T cells were injected i.p. into LAT Y136F neonates. At 6 wk after injection, lymph node and spleen cells were isolated and analyzed.
Real-time quantitative PCR and RT-PCR. Total RNAs were extracted with the Trizol reagent (Invitrogen) and reverse transcribed using Superscript II reverse transcriptase (Invitrogen). cDNAs were then used as templates in PCR amplifi cation with Taq polymerase. The Foxp3 mRNA level was quantifi ed using the LightCycler system (Roche). The primer pairs used in real-time PCR were the following: β-actin, 5′-A C T C C T A T G T G-G G T G A C G A G -3′, 5′-CAGGTC-C A G A C G C A G G A T G G C -3′; Foxp3, 5′-C C C A G G A A A G A C A G C A A C C T T -3′, 5′-TTCTCA-C A A C C A G G C-C A C T T G -3′. The primer pairs used in RT-PCR were the following:
Foxp3, 5′-C A G C T G C C T A C A G T G C C C C T A G -3′, 5′-C A T T T G C C-A G C A G T G G G T A G -3′; granzyme A, 5′-C T C A A G A C C G T A T A T G G-C T C T -3′, 5′-C C T G C A C A A A T C A T G T T T A G T -3′; granzyme B, 5′-A C T T T C G A T C A A G G A T C A G C A -3′, 5′-A C T G T C A G C T C A A C-C T C T T G T -3′; TGF-β1, 5′-T G C T G C T T T C T C C C T C A A C C T -3′, 5′-C A C T G C T T C C C G A A T G T C T G A -3′.
Immunohistochemistry. Whole spleens, livers, and kidneys were embedded in Tissue-Tek (Sankura Torrance) and sliced into 5-μm-thick section. Sections were applied to poly lysine-coated slides and fi xed in acetone. Spleen and liver sections were then stained with FITC-conjugated anti-B220 or biotin-conjugated anti-Thy1.2 followed by alkaline phosphataseconjugated anti-FITC and horseradish peroxidase-conjugated streptavidin (Sigma-Aldrich). Fast Blue BB and 3-aminoethylcarbazole (Sigma-Aldrich) solution were added for color development. Kidney sections were stained with FITC-anti-mouse IgG (BD Biosciences).
